T. Rowe Price Health Care ETF
TMED
4 hedge funds and large institutions have $1.66M invested in T. Rowe Price Health Care ETF in 2026 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
10.98% less ownership
Funds ownership: 18.17% → 7.19% (-11%)
51% less capital invested
Capital invested by funds: $3.42M → $1.66M (-$1.76M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$1.87M |
| 2 |
FTUS
Flow Traders U.S.
New York
|
-$262K |
| 3 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$12.3K |
TMED Hedge Fund Activity: Q2 2026 in Review
4 of the 8,330 institutional investors tracked by Wall St. Rank reported a position in T. Rowe Price Health Care ETF (TMED) for Q2 2026, worth a combined $1.66M — down 51% from $3.42M a quarter earlier.
Fund positioning in TMED was balanced in Q2 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 3 trimmed.
The largest seller was Citadel Advisors, cutting an estimated $1.87M.
- 4 institutional investors held T. Rowe Price Health Care ETF (TMED) as of Q2 2026, unchanged from Q1 2026.
- Funds reported $1.66M of T. Rowe Price Health Care ETF stock for Q2 2026, down 51% quarter-over-quarter.
- 0 funds opened new T. Rowe Price Health Care ETF positions in Q2 2026 and 0 closed out.
- The largest T. Rowe Price Health Care ETF seller in Q2 2026 was Citadel Advisors, an estimated $1.87M sold.
Based on aggregated 13F filings for Q2 2026.